BridgeMD
Tests treatment safety and results for Meibomian Gland Dysfunction
Official title Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction
ClinicalTrials.gov ID: NCT03767530
What this study is testing
- What it's testing
- Dry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfunction.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients diagnosed with:
- Dry eye syndrome with meibomian gland dysfunction alone or in combination of other type of dry eye.
- Patients who were previously treated with eyelid massages and warm compresses without any improvement.
You likely can't join if
- Pregnant women.
- History of ocular surgery within three months prior to inclusion.
- History of trauma, infection or inflammation within three months prior to inclusion.
- Contact lens use in the last week before inclusion.
- Patients with active ocular allergic disease.
- Patient with microbial keratitis.
The study team makes the final eligibility decision.
Where it's taking place
- Monterrey, Nuevo León, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Monterrey, Nuevo León, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.